1. Report Scope and Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2. Strategic Recommendations
3. Rheumatoid Arthritis Market: Product Outlook
4. Global Rheumatoid Arthritis Market: Sizing and Forecast
4.1 Global Rheumatoid Arthritis Market Size, By Value, 2016-2026
Table 1: Global Rheumatoid Arthritis Market Size, By Value, 2016-2026 (USD Million)
Table 2: Global Research and Development (% of GDP), 2015-2018
Table 3: GDP per Capita Growth (annual %), 2015-2019
Table 4: World Population 65 Years & Above (% of Total), 2015-2019
Table 5: Global Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Table 6: Global Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
4.2 Impact of COVID-19 on Global Rheumatoid Arthritis Market
5. Global Rheumatoid Arthritis Market Segmentation - By Drug Type, By Treatment, By Diagnosis
Table 12: Global Rheumatoid Arthritis Market- By Treatment Market Share, 2020 & 2026
5.1 Competitive Scenario of Global Rheumatoid Arthritis Market: By Drug Type
Table 7: Global Rheumatoid Arthritis Market- By Drug Type Market Share, 2020 & 2026
5.1.1 NSAID(non-steroidal anti-inflammatory drugs) - Market Size and Forecast (2016-2026)
Table 8: Global Rheumatoid Arthritis Market- By NSAID, By Value (USD Million), 2016-2026
5.1.2 DMARD'S(Disease-modifying anti-rheumatic drug) - Market Size and Forecast (2016-2026)
Table 9: Global Rheumatoid Arthritis Market- By DMARDS, By Value (USD Million), 2016-2026
5.1.3 Corticosteroids- Market Size and Forecast (2016-2026)
Table 10: Global Rheumatoid Arthritis Market- By Corticosteroids, By Value (USD Million), 2016-2026
5.1.4 Others - Market Size and Forecast (2016-2026)
Table 11: Global Rheumatoid Arthritis Market- By Others, By Value (USD Million), 2016-2026
5.2 Competitive Scenario of Global Rheumatoid Arthritis Market: By Treatment
5.2.1 Tendon Repair - Market Size and Forecast (2016-2026)
Table 13: Global Rheumatoid Arthritis Market- By Tendon Repair, By Value (USD Million), 2016-202
5.2.2 Joint Fusion- Market Size and Forecast (2016-2026)
Table 14: Global Rheumatoid Arthritis Market- By Joint Fusion, By Value (USD Million), 2016-2026
5.2.3 Joint Replacement- Market Size and Forecast (2016-2026)
Table 15: Global Rheumatoid Arthritis Market- By Joint Replacement, By Value (USD Million), 2016-2026
5.2.4 Others - Market Size and Forecast (2016-2026)
Table 16: Global Rheumatoid Arthritis Market- By Others, By Value (USD Million), 2016-2026
5.3 Competitive Scenario of Global Rheumatoid Arthritis Market: By Diagnosis
Table 17: Global Rheumatoid Arthritis Market- By Diagnosis Market Share, 2020 & 2026
5.3.1 CRP(Creative Protein Test) - Market Size and Forecast (2016-2026)
Table 18: Global Rheumatoid Arthritis Market- By CRP, By Value (USD Million), 2016-2026
5.3.2 ESR(Erythrocyte Sedimentation Rate)- Market Size and Forecast (2016-2026)
Table 19: Global Rheumatoid Arthritis Market- By ESR, By Value (USD Million), 2016-2026
5.3.3 Others - Market Size and Forecast (2016-2026)
Table 20: Global Rheumatoid Arthritis Market- By Others, By Value (USD Million), 2016-2026
6. Global Rheumatoid Arthritis Market: Regional Analysis
6.1 Competitive Scenario of Global Rheumatoid Arthritis Market: By Region
Table 21: Global Rheumatoid Arthritis Market- By Region Market Share, 2020 & 2026
7. Americas Rheumatoid Arthritis Market: Segmentation (By Drug Type, By Treatment, By Diagnosis)
7.1 Americas Rheumatoid Arthritis Market: Size and Forecast (2016-2026), By Value
Table 22: Americas Rheumatoid Arthritis Market Size, By Value, 2016-2026 (USD Million)
Table 23: Americas Biologic medicine share of total pharmaceutical sales, 2018 (Share of sales in %)
Table 24: North America Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Table 25: North America Population ages 65 and above (% of Total Population), 2016-2020
7.2 Americas Rheumatoid Arthritis Market - Prominent Companies
7.3 Market Segmentation By Drug Type (DMARDs, NSAID, Corticosteroidsand Others)
Table 26: Americas Rheumatoid Arthritis Market- By Drug Type, By Value (USD Million), 2016-2026
7.4 Market Segmentation By Treatment (Tendon Repair, Joint Fusion, Joint Replacement and Others)
Table 27: Americas Rheumatoid Arthritis Market- By Treatment, By Value (USD Million), 2016-2026
7.5 Market Segmentation By Diagnosis (CRP, ESR and Others)
Table 28: Americas Rheumatoid Arthritis Market- By Diagnosis, By Value (USD Million), 2016-2026
7.6 Americas Rheumatoid Arthritis Market: Country Analysis
7.7 Market Opportunity Chart of Americas Rheumatoid Arthritis Market - By Country, By Value, 2026
Table 29: Market Opportunity Chart of Americas Rheumatoid Arthritis Market- By Country, By Value (Year 2016-2026)
7.8 Competitive Scenario of Americas Rheumatoid Arthritis Market: By Country
Table 30: Americas Rheumatoid Arthritis Market- By Country Market Share, 2020 & 2026
7.9 United States Rheumatoid Arthritis Market: Size and Forecast (2016-2026), By Value
Table 31: United States Rheumatoid Arthritis Market Size, By Value, 2016-2026 (USD Million)
Table 32: United States Current health expenditure per capita (current USD), 2014-18
Table 33: United States Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Table 34: United States Population aged 65 and above (% of total Population), 2016-2020
7.10 United States Rheumatoid Arthritis Market Segmentation - By Drug Type, By Treatment, By Diagnosis (2016-2026)
Table 35: United States Rheumatoid Arthritis Market- By Drug Type, By Value (USD Million), 2016-2026
Table 36: United States Rheumatoid Arthritis Market- By Treatment, By Value (USD Million), 2016-2026
Table 37: United States Rheumatoid Arthritis Market- By Diagnosis, By Value (USD Million), 2016-2026
7.11 Canada Rheumatoid Arthritis Market: Size and Forecast (2016-2026), By Value
Table 38: Canada Rheumatoid Arthritis Market Size, By Value, 2016-2026 (USD Million)
Table 39: Canada Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Table 40: Canada Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Table 41: Canada Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
7.12 Canada Rheumatoid Arthritis Market Segmentation - By Drug Type, By Treatment, By Diagnosis (2016-2026)
Table 42: Canada Rheumatoid Arthritis Market- By Drug Type, By Value (USD Million), 2016-2026
Table 43: Canada Rheumatoid Arthritis Market- By Treatment, By Value (USD Million), 2016-2026
Table 44: Canada Rheumatoid Arthritis Market- By Diagnosis, By Value (USD Million), 2016-2026
8. Europe Rheumatoid Arthritis Market: Segmentation (By Drug Type, By Treatment, By Diagnosis)
8.1 Europe Rheumatoid Arthritis Market: Size and Forecast (2016-2026), By Value
Table 45: Europe Rheumatoid Arthritis Market Size, By Value, 2016-2026 (USD Million)
Table 46: Europe Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Table 47: Europe Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Table 48: European Countries Population ages 65 and above (% of total Population), 2020
8.2 Europe Rheumatoid Arthritis Market - Prominent Companies
8.3 Market Segmentation By Drug Type (DMARDs, NSAID, Corticosteroidsand Others)
Table 49: Europe Rheumatoid Arthritis Market- By Drug Type, By Value (USD Million), 2016-2026
8.4 Market Segmentation By Treatment (Tendon Repair, Joint Fusion, Joint Replacement and Others)
Table 50: Europe Rheumatoid Arthritis Market- By Drug Type, By Value (USD Million), 2016-2026
8.5 Market Segmentation By Diagnosis (CRP, ESR and Others)
Table 51: Europe Rheumatoid Arthritis Market- By Diagnosis, By Value (USD Million), 2016-2026
8.6 Europe Rheumatoid Arthritis Market: Country Analysis
8.7 Market Opportunity Chart of Europe Rheumatoid Arthritis Market - By Country, By Value, 2026
8.8 Competitive Scenario of Europe Rheumatoid Arthritis Market: By Country
8.9 Germany Rheumatoid Arthritis Market: Size and Forecast (2016-2026), By Value
Table 54: Germany Rheumatoid Arthritis Market Size, By Value, 2016-2026 (USD Million)
Table 55: Germany Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Table 56: Germany Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Table 57: Germany Urban population, 2015-2019 (In %)
8.10 Germany Rheumatoid Arthritis Market Segmentation - By Drug Type, By Treatment, By Diagnosis (2016-2026)
Table 58: Germany Rheumatoid Arthritis Market- By Drug Type, By Value (USD Million), 2016-2026
Table 59: Germany Rheumatoid Arthritis Market- By Treatment, By Value (USD Million), 2016-2026
Table 60: Germany Rheumatoid Arthritis Market- By Diagnosis, By Value (USD Million), 2016-2026
8.11 United Kingdom Rheumatoid Arthritis Market: Size and Forecast (2016-2026), By Value
Table 61: United Kingdom Rheumatoid Arthritis Market Size, By Value, 2016-2026 (USD Million)
Table 62: United Kingdom Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Table 63: United Kingdom Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Table 64: United Kingdom Population ages 65 and above (% of Total Population), 2016-20
8.12 United Kingdom Rheumatoid Arthritis Market Segmentation - By Drug Type, By Treatment, By Diagnosis (2016-2026)
Table 65: United Kingdom Rheumatoid Arthritis Market- By Drug Type, By Value (USD Million), 2016-2026
Table 66: United Kingdom Rheumatoid Arthritis Market- By Treatment, By Value (USD Million), 2016-2026
Table 67: United Kingdom Rheumatoid Arthritis Market- By Diagnosis, By Value (USD Million), 2016-2026
8.13 France Rheumatoid Arthritis Market: Size and Forecast (2016-2026), By Value
Table 68: France Rheumatoid Arthritis Market Size, By Value, 2016-2026 (USD Million)
Table 69: France Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Table 70: France Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Table 71: France Population ages 65 and above (% of Total Population), 2016-20
8.14 France Rheumatoid Arthritis Market Segmentation - By Drug Type, By Treatment, By Diagnosis (2016-2026)
Table 72: France Rheumatoid Arthritis Market- By Drug Type, By Value (USD Million), 2016-2026
Table 73: France Rheumatoid Arthritis Market- By Treatment, By Value (USD Million), 2016-2026
Table 74: France Rheumatoid Arthritis Market- By Diagnosis, By Value (USD Million), 2016-2026
8.15 Italy Rheumatoid Arthritis Market: Size and Forecast (2016-2026), By Value
Table 75: Italy Rheumatoid Arthritis Market Size, By Value, 2016-2026 (USD Million)
Table 76: Italy Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Table 77: Italy Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Table 78: Italy Population ages 65 and above (% of total Population), 2016-20
8.16 Italy Rheumatoid Arthritis Market Segmentation - By Drug Type, By Treatment, By Diagnosis (2016-2026)
Table 79: Italy Rheumatoid Arthritis Market- By Drug Type, By Value (USD Million), 2016-2026
Table 80: Italy Rheumatoid Arthritis Market- By Treatment, By Value (USD Million), 2016-2026
Table 81: Italy Rheumatoid Arthritis Market- By Diagnosis, By Value (USD Million), 2016-2026
8.17 Spain Rheumatoid Arthritis Market: Size and Forecast (2016-2026), By Value
Table 82: Spain Rheumatoid Arthritis Market Size, By Value, 2016-2026 (USD Million)
Table 83: Spain Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Table 84: Spain Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Table 85 Spain Urban population, 2016-2020 (In %)
8.18 Spain Rheumatoid Arthritis Market Segmentation - By Drug Type, By Treatment, By Diagnosis (2016-2026)
Table 86: Spain Rheumatoid Arthritis Market- By Drug Type, By Value (USD Million), 2016-2026
Table 87: Spain Rheumatoid Arthritis Market- By Drug Type, By Value (USD Million), 2016-2026
Table 88: Spain Rheumatoid Arthritis Market- By Diagnosis, By Value (USD Million), 2016-2026
9. Asia Pacific Rheumatoid Arthritis Market: Segmentation (By Drug Type, By Treatment, By Diagnosis)
9.1 Asia Pacific Rheumatoid Arthritis Market: Size and Forecast (2016-2026), By Value
Table 89: Asia Pacific Rheumatoid Arthritis Market Size, By Value, 2016-2026 (USD Million)
Table 90: Asia Pacific Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Table 91: Asia Pacific Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Table 92: Asia Pacific Population ages 65 and above, by Countries (% of total Population), 2020
9.2 Asia Pacific Rheumatoid Arthritis Market - Prominent Companies
9.3 Market Segmentation By Drug Type (DMARDs, NSAID, Corticosteroidsand Others)
Table 93: Asia Pacific Rheumatoid Arthritis Market- By Drug Type, By Value (USD Million), 2016-2026
9.4 Market Segmentation By Treatment (Tendon Repair, Joint Fusion, Joint Replacement and Others)
Table 94: Asia Pacific Rheumatoid Arthritis Market- By Treatment, By Value (USD Million), 2016-2026
9.5 Market Segmentation By Diagnosis (CRP, ESR and Others)
Table 95: Asia Pacific Rheumatoid Arthritis Market- By Diagnosis, By Value (USD Million), 2016-2026
9.6 Asia Pacific Rheumatoid Arthritis Market: Country Analysis
9.7 Market Opportunity Chart of Asia Pacific Rheumatoid Arthritis Market - By Country, By Value, 2026
Table 96: Market Opportunity Chart of APAC Rheumatoid Arthritis Market- By Country, By Value (Year-2026)
9.8 Competitive Scenario of Asia Pacific Rheumatoid Arthritis Market: By Country
Table 97: APAC Rheumatoid Arthritis Market- By Country Market Share, 2020 & 2026
9.9 China Rheumatoid Arthritis Market: Size and Forecast (2016-2026), By Value
Table 98: China Rheumatoid Arthritis Market Size, By Value, 2016-2026 (USD Million)
Table 99: China Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Table 100: China Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Table 101: China Population ages 65 and above (% of Total Population), 2016-20
9.10 China Rheumatoid Arthritis Market Segmentation - By Drug Type, By Treatment, By Diagnosis (2016-2026)
Table 102: China Rheumatoid Arthritis Market- By Drug Type, By Value (USD Million), 2016-2026
Table 103: China Rheumatoid Arthritis Market- By Treatment, By Value (USD Million), 2016-2026
Table 104: China Rheumatoid Arthritis Market- By Diagnosis, By Value (USD Million), 2016-2026
9.11 Japan Rheumatoid Arthritis Market: Size and Forecast (2016-2026), By Value
Table 105: Japan Rheumatoid Arthritis Market Size, By Value, 2016-2026 (USD Million)
Table 106: Japan Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Table 107: Japan Current Healthcare Expenditure as a percentage of GDP, 2015-2018 (In %)
Table 108: Japan Population ages 65 and above (% of Total Population), 2016-20
9.12 Japan Rheumatoid Arthritis Market Segmentation - By Drug Type, By Treatment, By Diagnosis (2016-2026)
Table 109: Japan Rheumatoid Arthritis Market- By Drug Type, By Value (USD Million), 2016-2026
Table 110: Japan Rheumatoid Arthritis Market- By Treatment, By Value (USD Million), 2016-2026
Table 111: Japan Rheumatoid Arthritis Market- By Diagnosis, By Value (USD Million), 2016-2026
9.13 India Rheumatoid Arthritis Market: Size and Forecast (2016-2026), By Value
Table 112: India Rheumatoid Arthritis Market Size, By Value, 2016-2026 (USD Million)
Table 113: India Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Table 114: India Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Table 115: India Population ages 65 and above (% of Total Population), 2016-20
9.14 India Rheumatoid Arthritis Market Segmentation - By Drug Type, By Treatment, By Diagnosis (2016-2026)
Table 116: India Rheumatoid Arthritis Market- By Drug Type, By Value (USD Million), 2016-2026
Table 117: India Rheumatoid Arthritis Market- By Treatment, By Value (USD Million), 2016-2026
Table 118: India Rheumatoid Arthritis Market- By Treatment, By Value (USD Million), 2016-2026
10. Global Rheumatoid Arthritis Market Dynamics
10.1 Drivers
10.2 Restraints
10.3 Trends
11. Market Attractiveness
11.1 Market Attractiveness Chart of Global Rheumatoid Arthritis Market - By Drug Type, 2026
Table 119: Market Attractiveness Chart of Global Rheumatoid Arthritis Market- By Drug Type (2016-2026)
11.2 Market Attractiveness Chart of Global Rheumatoid Arthritis Market - By Treatment, 2026
Table 120: Market Attractiveness Chart of Global Rheumatoid Arthritis Market- By Treatment (2016-2026)
11.3 Market Attractiveness Chart of Global Rheumatoid Arthritis Market - By Diagnosis, 2026
Table 121: Market Attractiveness Chart of Global Rheumatoid Arthritis Market- By Diagnosis 2016-2026)
11.4 Market Attractiveness Chart of Global Rheumatoid Arthritis Market - By Region, 2026
Table 122: Market Attractiveness Chart of Global Rheumatoid Arthritis Market- By Region (2016-2026)
12. Competitive Landscape
12.1 Product Pipeline of Leading Rheumatoid Arthritis Companies
12.2 Market Share Analysis
Table 123: Global Rheumatoid Arthritis company market share (%), 2020
13. Company Analysis
13.1 Merck KGaA
13.2 Sanofi
Table 128: Sanofi Sales Revenues, 2016-2020 (USD Million)
Table 129: Sanofi Gross Profit, 2016-2020 (USD Million)
Table 130: Sanofi Sales Revenue Split, By Business Segment (%), FY2020
Table 131: Sanofi Sales Revenue Split, By Geography Segment (%), FY2020
13.3 Eli Lilly Company
Table 132: Eli Lilly and Company Annual Sales Revenue (USD Million), 2016-2020
Table 133: Eli Lilly and Company Annual Net Income (USD Million), 2016-2020
Table 134: Eli Lilly and Company Sales Revenue Split, By Business Segment (USD Million), FY2020
Table 135: Eli Lilly and Company Sales Revenue Split, By Geography Segment (%), FY2020
13.4 Amgen Inc.
Table 136: Amgen Inc. Sales Revenues, 2016-2020 (USD Million)
Table 137: Amgen Inc. Net Income, 2016-2020 (USD Million)
Table 138: Amgen Inc. Sales Revenue Split, By Business Segment (%), FY2020
Table 139: Amgen Inc. Sales Revenue Split, By Geography Segment (%), FY2020
13.5 Bristol-Mayor Squibb
Table 140: Bristol-Myers Squibb Sales Revenues, 2016-2020 (USD Million)
Table 141: Bristol-Myers Squibb Net Income, 2016-2020 (USD Million)
Table 142: Bristol-Myers Squibb Sales Revenue Split, By Business Segment (%), FY2020
Table 143: Bristol-Myers Squibb Sales Revenue Split, By Geography Segment (%), FY2020
13.6 F. Hoffman-La Roche Ltd.
Table 144: F. Hoffman-La Roche Ltd. Sales Revenues, 2016-2020 (USD Million)
Table 145: F. Hoffman-La Roche Ltd. Net Income, 2016-2020 (USD Million)
Table 146: F. Hoffman-La Roche Ltd. sales Revenues, By Business Segment (%), FY2020
Table 147: F. Hoffman-La Roche Ltd. sales Revenue, By Geographical Segment (%), FY2020
13.7 Johnson & Johnson
Table 148: Johnson & Johnson Annual Sales Revenue (USD Billion), 2016-2020
Table 149: Johnson & Johnson Annual Net Income/Loss (USD Billion), 2016-2020
Table 150: Johnson & Johnson Sales Revenue Split, By Business Segment (%), FY2020
Table 151: Johnson & Johnson Sales Revenue Split, By Geography Segment (%), FY2020
13.8 Cipla
Table 152: Cipla Sales Revenues, 2016-2020 (USD Million)
Table 153: Cipla sales Revenues, By Business Segment (%), FY2020
Table 154: Cipla sales Revenue, By Geographical Segment (%), FY2020
13.9 Pfizer
Table 155: Pfizer Annual Sales Revenue (USD Million), 2016-2020
Table 156: Pfizer Annual Net Income/Loss (USD Million), 2016-2020
Table 157: Pfizer sales Revenue, By Geographical Segment (%), FY2020
13.10 Galapagos NV
Table 158: Galapagos NV Annual Sales Revenue (USD Million), 2016-2020
Table 159: Galapagos NV sales Revenue, By Geographical Segment (%), FY2020
13.11 Gilead Sciences
Table 160: Gilead Sciences Annual Sales Revenue (USD Million), 2016-2020
Table 161: Gilead Sciences Annual Net Income (USD Million), 2016-2019